Kozhnosys

Pune, India Founded: 2017 • Age: 9 yrs
Developer of breath analyzers to detect diseases
Annual revenue $15,522 Latest available
Total funding $284,912 3 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products 3 Services tracked
Competitors 3 Brand Intelligence

About Kozhnosys

Kozhnosys is a company based in Pune (India) founded in 2017 by Suman Mohandas Kolarath. Kozhnosys has raised $284.91 thousand across 3 funding rounds from investors including Startups at Venture Center, Edney Enterprises and Venture Center. Kozhnosys offers products and services including CanScan, XSampler, and Xalo. Kozhnosys operates in a competitive market with competitors including Dognostica and SpiraCheck, among others.

  • Headquarter Pune, India
  • Founders Suman Mohandas Kolarath
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Kozhnosys Private Limited
  • Date of Incorporation 21 Jul, 2017
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $15.52 K (USD)
    45.09
    as on Mar 31, 2022
  • Net Profit
    -$14.85 K (USD)
    -144.9
    as on Mar 31, 2022
  • EBITDA
    -$27.56 K (USD)
    -77.99
    as on Mar 31, 2022
  • Total Equity Funding
    $284.91 K (USD)

    in 3 rounds

  • Latest Funding Round
    $174.18 K (USD), Seed

    Aug 24, 2023

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kozhnosys

Kozhnosys offers a comprehensive portfolio of products and services, including CanScan, XSampler, and Xalo.

Product name locked
Category locked
Primary

Breath analyzer for early breast cancer detection with high accuracy.

Product name locked
Category locked
Locked

Device for collecting breath samples for disease analysis.

Product name locked
Category locked
Locked

Technology for processing breath data to identify health conditions.

Funding Insights of Kozhnosys

Kozhnosys has successfully raised a total of $284.91K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $174.18 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Kozhnosys

Kozhnosys has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Startups at Venture Center, Edney Enterprises and Venture Center.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Startups are incubated at Venture Center, backed by CSIR.
Locked Locked Locked
Startup incubator focused on science business
Locked Locked Locked

Suman Mohandas Kolarath

-
Locked Locked Locked
Premium access

Investor details for Kozhnosys

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kozhnosys

Investments
Premium access

Investment portfolio details for Kozhnosys

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kozhnosys

Premium access

Detailed financials for Kozhnosys

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kozhnosys Comparisons

Kozhnosys Primary company
Description
Developer of breath analyzers to detect diseases
Location
Pune, India
Founded Year
2017
Annual Revenue
$15.52 K (USD)
Net Profit
-$14.85 K (USD)
EBITDA
-$27.56 K (USD)
Employees
Not available
Premium access

Peer comparison for Kozhnosys

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kozhnosys

Kozhnosys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dognostica and SpiraCheck, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of canine-assisted cancer screening
Locked Locked Locked
Develops breath tests for early detection of multiple cancers to improve survival.
Premium access

Detailed competitors of Kozhnosys

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kozhnosys

Premium access

Complete news archive for Kozhnosys

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kozhnosys

Kozhnosys was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Kozhnosys is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Kozhnosys is a funded company, having raised a total of $284.91K across 3 funding rounds to date.

Annual revenue of Kozhnosys is $15.52K as on Mar 31, 2022.

Developer of breath analyzers to detect diseases. The company is developing a bio-sensor-based device for the detection of volatile markers to analyze breath and cancer. The products inlcude CanScan to detect cancer through breathing and Xalo to monitor health parameters.

Kozhnosys's top competitors include Dognostica and SpiraCheck.

Kozhnosys offers CanScan, XSampler, and Xalo.

Kozhnosys has 4 investors. Key investors include Startups at Venture Center, Edney Enterprises, Venture Center, and Suman Mohandas Kolarath.

The valuation of Kozhnosys is $1.37M as of Aug 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available